INFOGRAPHIC: IPOs surge in first half of 2014; 41 companies raise $2.6bn
This article was originally published in Scrip
Executive Summary
Could the number of biotechnology companies that go public in the US double in 2014 versus last year? Well, with 41 drug developers who completed initial public offerings as of 30 June, the industry already exceeded the 37 companies that completed IPOs in 2013.